Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ITRM
#5194
Iterum Therapeutics plc Ordinary Share
0.0
3
USD
-57.14%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-57.14%
Monthly Change
-81.25%
6 month change
-95.77%
Year Change
-97.56%
Previous Close
0.0
7
Open
0.0
3
Bid
Ask
Low
0.0
3
High
0.0
3
Volume
20
Markets
US Stock Market
Healthcare
ITRM
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Cash from operating activities
-4.26 M
-3.06 M
-4.75 M
-7.45 M
-19.51 M
Cash from investing activities
1.1 M
-2 000
0
-12 K
1.09 M
Cash from financing activities
13.88 M
-8.39 M
5.12 M
5.43 M
16.04 M
Free cash flow
-4.26 M
-3.06 M
-4.75 M
-7.46 M
-19.53 M
News
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.72%
Iterum Therapeutics requests Nasdaq hearing after delisting notice
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.83%
Iterum Therapeutics expands Medicare Part D access for ORLYNVAH
Iterum Therapeutics expands market access for ORLYNVAH antibiotic
Iterum Therapeutics secures major PBM agreement for antibiotic
Iterum Therapeutics receives Nasdaq notice on listing compliance
Iterum Therapeutics expands reimbursement coverage for ORLYNVAH
Iterum’s antibiotic ORLYNVAH now available through McKesson
Iterum Therapeutics director Dunne buys $2,191 in shares
Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript
Allianz, Richemont, Swiss Re, and more set to report earnings Friday